ITNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by newcastle disease virus

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1814-1821

  Washburn, Birgit ^a   Weigand, Markus A ^a,b   Grosse Wilde, Anne ^a   Janke, Markus ^a   Stahl, Heiko ^a   Rieser, Eva ^a   Sprick, Martin R ^a   Schirrmacher, Volker ^a   Walczak, Henning ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE PROTEIN; TNFRSF10A PROTEIN, HUMAN; TNFRSF10B PROTEIN, HUMAN; TNFRSF10C PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR DECOY RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONOCYTE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INACTIVATION; VIRUS REPLICATION; BIOSYNTHESIS; CELL CULTURE; CELL MEMBRANE; CYTOTOXICITY TEST; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; UPREGULATION; VIROLOGY;

ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL MEMBRANE; CYTOTOXICITY TESTS, IMMUNOLOGIC; HUMANS; LIGANDS; MACROPHAGE ACTIVATION; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MONOCYTES; NEWCASTLE DISEASE VIRUS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VIRUS REPLICATION;

EID: 0037441854     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1814     Document Type: Article

References (34)

1. Nelson, N. J. 1999. Scientific interest in Newcastle disease virus is reviving. J. Natl. Cancer Inst. 91:1708.
2. Schirrmacher, V., T. Ahlert, T. Probstle, H. H. Steiner, C. Herold-Mende, R. Gerhards, E. Hagmuller, and H. H. Steiner. 1998. Immunization with virusmodified tumor cells. Semin. Oncol. 25:677.
3. Cassel, W. A., and D. R. Murray. 1992. A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate. Med. Oncol. Tumor Pharmacother. 9:169.
4. Termeer, C. C., V. Schirrmacher, E. B. Brocker, and J. C. Becker. 2000. Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells. Cancer Gene Ther. 7:316.
5. Nagai, Y., M. Hamaguchi, and T. Toyoda. 1989. Molecular biology of Newcastle disease virus. Prog. Vet. Microbiol. Immunol. 5:16.
6. Schirrmacher, V., C. Haas, R. Bonifer, T. Ahlert, R. Gerhards, and C. Ertel. 1999. Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Gene Ther. 6:63.
7. Lorence, R. M., P. A. Rood, and K. W. Kelley. 1988. Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-α and augmentation of its cytotoxicity. J. Natl. Cancer Inst. 80:1305.
8. Hoss-Homfeld, A., E. C. Zwarthoff, and R. Zawatzky. 1989. Cell type specific expression and regulation of murine interferon α and β genes. Virology 173:539.
9. Wertz, K., M. Buttner, A. Mayr, and O. R. Kaaden. 1994. More than one component of the Newcastle disease virus particle is capable of interferon induction. Vet. Microbiol. 39:299.
10. Zorn, U., I. Dallmann, J. Grosse, H. Kirchner, H. Poliwoda, and J. Atzpodien. 1994. Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virus. Cancer Biother. 9:225.
11. Schirrmacher, V. 1986. Mechanisms of metastatic spread to liver. Recent Results Cancer Res. 100:23.
12. Schirrmacher, V., L. Bai, V. Umansky, L. Yu, Y. Xing, and Z. Qian. 2000. Newcastle disease virus activates macrophages for anti-tumor activity. Int. J. Oncol. 16:363.
13. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
14. Krammer, P. H. 1999. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71:163.
15. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331.
16. Walczak, H., R. E. Miller, K. Ariail, B. Gliniak, T. S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, T. Le, et al. 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5:157.
17. Ashkenazi, A., R. C. Pai, S. Fong, S. Leung, D. A. Lawrence, S. A. Marsters, C. Blackie, L. Chang, A. E. McMurtrey, A. Hebert, et al. 1999. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104:155.
18. Chuntharapai, A., K. Dodge, K. Grimmer, K. Schroeder, S. A. Marsters, H. Koeppen, A. Ashkenazi, and K. J. Kim. 2001. Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J. Immunol. 166:4891.
19. Ichikawa, K., W. Liu, L. Zhao, Z. Wang, D. Liu, T. Ohtsuka, H. Zhang, J. D. Mountz, W. J. Koopman, R. P. Kimberly, et al. 2001. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat. Med. 7:954.
20. Walczak, H., and P. H. Krammer. 2000. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell. Res. 256:58.
21. Griffith, T. S., S. R. Wiley, M. Z. Kubin, L. M. Sedger, C. R. Maliszewski, and N. A. Fanger. 1999. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine. TRAIL. J. Exp. Med. 189:1343.
22. Fanger, N. A., C. R. Maliszewski, K. Schooley, and T. S. Griffith. 1999. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 190:1155.
23. Sedger, L. M., D. M. Shows, R. A. Blanton, J. J. Peschon, R. G. Goodwin, D. Cosman, and S. R. Wiley. 1999. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 163:920.
24. Vidalain, P. O., O. Azocar, B. Lamouille, A. Astier, C. Rabourdin-Combe, and C. Servet-Delprat. 2000. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74:556.
25. Takeda, K., Y. Hayakawa, M. J. Smyth, N. Kayagaki, N. Yamaguchi, S. Kakuta, Y. Iwakura, H. Yagita, and K. Okumura. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7:94.
26. Smyth, M. J., E. Cretney, K. Takeda, R. H. Wiltrout, L. M. Sedger, N. Kayagaki, H. Yagita, and K. Okumura. 2001. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193:661.
27. Russell, P. H., and D. J. Alexander. 1983. Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies. Arch. Virol. 75:243.
28. Walczak, H., M. A. Degli-Esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh, N. Boiani, M. S. Timour, M. J. Gerhart, K. A. Schooley, C. A. Smith, et al. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16:5386.
29. Dhein, J., H. Walczak, C. Baumier, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
30. Umansky, V., V. A. Shatrov, V. Lehmann, and V. Schirrmacher. 1996. Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-κB. Int. Immunol. 8:491.
31. + T cell-mediated cytotoxicity. J. Immunol. 162:2639.
32. Nakayama, M., N. Kayagaki, N. Yamaguchi, K. Okumura, and H. Yagita. 2000, Involvement of TWEAK in interferon γ-stimulated monocyte cytotoxicity. J. Exp. Med. 192:1373.
33. Manna, S. K., A. Mukhopadhyay, and B. B. Aggarwal. 2000. IFN-α suppresses activation of nuclear transcription factor NF-κB and activator protein 1 and potentiates TNF-induced apoptosis. J. Immunol. 165:4927.
34. Clarke, P., S. M. Meintzer, S. Gibson, C. Widmann, T. P. Garrington, G. L. Johnson, and K. L. Tyler. 2000. Reovirus-induced apoptosis is mediated by TRAIL. J. Virol. 74:8135.